Evidence map›Paper›PMID 15302821›Full record

ArticleEukaryotic cell2004

Differential regulation of ceramide synthase components LAC1 and LAG1 in Saccharomyces cerevisiae.

Marcin Kolaczkowski, Anna Kolaczkowska, Barbara Gaigg, Roger Schneiter, W Scott Moye-Rowley

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Phenotype to genotype inCurrent research in microbial sciences · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Point centromere activity requires an optimal level of centromeric noncoding RNA.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Marcin KolaczkowskiDepartment of Physiology and Biophysics, 6-530 Bowen Science Building, University of Iowa, Iowa City, IA 52242, USA.
Anna Kolaczkowska
Barbara Gaigg
Roger Schneiter
W Scott Moye-Rowley
University of Fribourg · CHUniversity of Iowa · USUniversity of Wrocław · PLWroclaw Medical University · PL

Funding

GENETIC ANALYSIS OF PLEIOTROPIC DRUG RESISTANCER01GM049825 · NIGMS · UNIVERSITY OF IOWA · PI MOYE-ROWLEY, W SCOTT · 1993 to 2019
$6.0M
NIGMS NIH HHS GM 49825NIGMS NIH HHS R01 GM049825PHS HHS 6P05 A 01221
6 · The paper itself

Abstract

In Saccharomyces cerevisiae, the essential ceramide synthase reaction requires the presence of one of a homologous pair of genes, LAG1 and LAC1. Mutants that lack both of these genes cannot produce ceramide and exhibit a striking synthetic growth defect. While the regulation of ceramide production is critical for the control of proliferation and for stress tolerance, little is known of the mechanisms that ensure proper control of this process. The data presented here demonstrate that the pleiotropic drug resistance (Pdr) regulatory pathway regulates the transcription of multiple genes encoding steps in sphingolipid biosynthesis, including LAC1. The zinc cluster transcriptional activators Pdr1p and Pdr3p bind to Pdr1p/Pdr3p-responsive elements (PDREs) in the promoters of Pdr pathway target genes. LAC1 contains a single PDRE in its promoter, but notably, LAG1 does not. Reporter gene, Northern blot, and Western blot assays indicated that the expression level of Lac1p is approximately three times that of Lag1p. Detailed analyses of the LAC1 promoter demonstrated that transcription of this gene is inhibited by the presence of the transcription factor Cbf1p and the anaerobic repressor Rox1p. LAG1 transcription was also elevated in cbf1Delta cells, indicating at least one common regulatory input. Although a hyperactive Pdr pathway altered the profile of sphingolipids produced, the loss of either LAC1 or LAG1 alone failed to produce further changes. Two other genes involved in sphingolipid biosynthesis (LCB2 and SUR2) were found to contain PDREs in their promoters and to be induced by the Pdr pathway. These data demonstrate extensive coordinate control of sphingolipid biosynthesis and multidrug resistance in yeast.

Indexed as

Gene Expression Regulation, FungalDNA-Binding ProteinsDrug Resistance, MicrobialGenes, ReporterMembrane ProteinsOxidoreductasesPromoter Regions, GeneticRepressor ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSphingolipidsTrans-ActivatorsTranscription FactorsTranscription, Geneticdihydroceramide desaturaseDNA-Binding ProteinsLAC1 protein, S cerevisiaeLAG1 protein, S cerevisiaeMembrane ProteinsOxidoreductasesPDR1 protein, S cerevisiaePDR3 protein, S cerevisiaeRepressor ProteinsSaccharomyces cerevisiae ProteinsSphingolipidsTrans-ActivatorsTranscription Factors

Identifiers

PMID15302821
PMCPMC500886
OpenAlexW2110551051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.